Corporate Members

Corporate Members

Opportunities are available for companies to join us as Corporate Members.  Benefits include a reduction in the exhibition fee at the annual meeting and a number of free registrations for staff to attend.  The cost per annum starts at €5,000.  If you are interested, please contact Anne Taft at the EVF office (admin@europeanvenousforum.org) for further information.

Founded in 1912, the medium-sized company Kreussler Pharma is the originator of Aethoxysklerol^® (active ingredient Polidocanol) for sclerotherapy of all types of varicose veins. Sold in more than 50 countries, Aethoxysklerol^® is widely considered as the world’s leading sclerosing agent. Recent milestones were FDA approval (Asclera^®) in the USA and foam approval in several European countries.

For further information on Kreussler Pharma, please visit their website: http://www.aethoxysklerol-international.com